Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma

Yasuhiro Oki, Anas Younes, Javier Knickerbocker, Felipe Samaniego, Loretta Nastoupil, Fredrick Hagemeister, Jorge Romaguera, Nathan Fowler, Larry Kwak, Jason Westin

Research output: Contribution to journal › Letter › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma'. Together they form a unique fingerprint.